The intricate connection between systemic health and dermatology has been made clear by the COVID-19 pandemic. Acute symptoms including rashes, livedo reticularis, and chilblain-like lesions are among the dermatological manifestations of COVID-19. Long-term effects include pigmentary alterations and telogen effluvium. These cutaneous symptoms highlight the skin’s function as a systemic health marker and can offer crucial diagnostic hints, especially in instances that are asymptomatic or very mildly symptomatic. Although the COVID-19 vaccine has been crucial in preventing serious illness, it has also resulted in dermatological side effects, such as delayed injection site reactions, acute hypersensitivity reactions, and uncommon skin conditions linked to autoimmune diseases. Although the majority of vaccine-induced skin reactions are minor and resolve on their own, it is crucial to identify them in order to allay patient fears and counteract vaccine reluctance. In order to promote early detection and customized patient care, dermatologists have played a crucial role in the diagnosis and treatment of COVID-19-related skin disorders. Furthermore, their involvement in resolving vaccine-related issues emphasizes the necessity of multidisciplinary public health strategies. Ongoing studies into cutaneous biomarkers, vaccine effects, and post-COVID skin problems will further integrate dermatology into systemic disease treatment as the pandemic moves into an endemic phase, improving patient outcomes and influencing future medical procedures.